Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S)-2-((5S,8S,11S,14S)-5-((1H-indol-3-yl)methyl)-14-amino-8,11-bis(4-aminobutyl)-2-benzhydryl-15-(1H-indol-3-yl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecanamido)-6-amino-N-((S)-6-amino-1-((S)-1-((S)-1,6-diamino-1-oxohexan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-1-oxohexan-2-yl)hexanamide
ID: ALA5280637
Max Phase: Preclinical
Molecular Formula: C78H106N18O9
Molecular Weight: 1439.82
Associated Items: